Catalent, Inc.

NYSE:CTLT 株式レポート

時価総額:US$10.9b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Catalent マネジメント

マネジメント 基準チェック /24

Catalent'sの CEO はAlessandro Maselliで、 Jul2022年に任命され、 の在任期間は 2.08年です。 の年間総報酬は$ 6.58Mで、 14%給与と86%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.025%を直接所有しており、その価値は$ 2.65M 。経営陣と取締役会の平均在任期間はそれぞれ1.8年と9年です。

主要情報

Alessandro Maselli

最高経営責任者

US$6.6m

報酬総額

CEO給与比率14.0%
CEO在任期間2.2yrs
CEOの所有権0.02%
経営陣の平均在職期間1.9yrs
取締役会の平均在任期間9.1yrs

経営陣の近況

Recent updates

Catalent, Inc.'s (NYSE:CTLT) Share Price Not Quite Adding Up

Aug 30
Catalent, Inc.'s (NYSE:CTLT) Share Price Not Quite Adding Up

Are Investors Undervaluing Catalent, Inc. (NYSE:CTLT) By 24%?

Jul 23
Are Investors Undervaluing Catalent, Inc. (NYSE:CTLT) By 24%?

Beyond Elevidys: Unveiling The Competitive Landscape Of Duchenne's Muscular Dystrophy

Jun 25

Catalent - Novo Holdings Merger: Attractive Spread

Feb 07

Catalent: Debt Remains An Overhang

Dec 13

Catalent Remains Overvalued

Oct 04

Calculating The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)

Aug 14
Calculating The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)

Catalent: Myriad Issues To Fix

Jul 31

Catalent (NYSE:CTLT) Has A Somewhat Strained Balance Sheet

May 05
Catalent (NYSE:CTLT) Has A Somewhat Strained Balance Sheet

A Look At The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)

Mar 27
A Look At The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)

Why did Catalent stock soar today? Potential takeover by Danaher

Feb 06

We Think Catalent (NYSE:CTLT) Is Taking Some Risk With Its Debt

Feb 01
We Think Catalent (NYSE:CTLT) Is Taking Some Risk With Its Debt

Catalent to make Sarepta Therapeutics' muscle wasting gene therapy under supply deal

Jan 05

An Intrinsic Calculation For Catalent, Inc. (NYSE:CTLT) Suggests It's 27% Undervalued

Dec 27
An Intrinsic Calculation For Catalent, Inc. (NYSE:CTLT) Suggests It's 27% Undervalued

Humanigen to pay Catalent Pharma $12M to settle supply agreement dispute

Dec 22

Catalent falls after new short call from Glasshouse Research

Dec 08

Catalent Q1 2023 Earnings Preview

Oct 31

These 4 Measures Indicate That Catalent (NYSE:CTLT) Is Using Debt Extensively

Oct 26
These 4 Measures Indicate That Catalent (NYSE:CTLT) Is Using Debt Extensively

Catalent: Charting A Post-Covid Future

Oct 19

CEO報酬分析

Catalent の収益と比較して、Alessandro Maselli の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$1b

Mar 31 2024n/an/a

-US$1b

Dec 31 2023n/an/a

-US$1b

Sep 30 2023n/an/a

-US$1b

Jun 30 2023US$7mUS$925k

-US$256m

Mar 31 2023n/an/a

US$21m

Dec 31 2022n/an/a

US$389m

Sep 30 2022n/an/a

US$399m

Jun 30 2022US$3mUS$654k

US$483m

Mar 31 2022n/an/a

US$485m

Dec 31 2021n/an/a

US$561m

Sep 30 2021n/an/a

US$544m

Jun 30 2021US$5mUS$640k

US$529m

Mar 31 2021n/an/a

US$494m

Dec 31 2020n/an/a

US$289m

Sep 30 2020n/an/a

US$250m

Jun 30 2020US$3mUS$483k

US$173m

Mar 31 2020n/an/a

US$104m

Dec 31 2019n/an/a

US$124m

Sep 30 2019n/an/a

US$138m

Jun 30 2019US$2mUS$450k

US$132m

報酬と市場: Alessandroの 総報酬 ($USD 6.58M ) は、 US市場 ($USD 13.17M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Alessandroの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Alessandro Maselli (52 yo)

2.2yrs

在職期間

US$6,583,672

報酬

Mr. Alessandro Maselli has been President of Catalent Pharma Solutions, Inc. from February 2019 and serves as its Director since July 01, 2022 and is its Chief Executive Officer and was its Chief Operation...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
John Greisch
Executive Chairman of the Board6.6yrsUS$400.86k0.028%
$ 3.0m
Alessandro Maselli
President2.2yrsUS$6.58m0.025%
$ 2.7m
Aristippos Gennadios
Group President of Pharma & Consumer Health Segment5.7yrsUS$3.80m0.063%
$ 6.9m
Ricky Hopson
President1.2yrsUS$972.31k0.017%
$ 1.8m
Matti Masanovich
Senior VP & CFO1.2yrsデータなし0.0051%
$ 560.5k
Michael Hatzfeld
VP & Chief Accounting Officerless than a yearデータなしデータなし
Charles Lickfold
Senior VP & Chief Information Officer4.3yrsデータなし0.0060%
$ 656.9k
Paul Surdez
Vice President of Investor Relations4.7yrsデータなしデータなし
Joseph Ferraro
Senior VP1.6yrsデータなし0.00061%
$ 66.8k
Michael Grippo
Senior Vice President of Strategy & Corporate Development4.9yrsデータなし0.013%
$ 1.4m
Lisa Evoli
Senior VP & Chief Human Resources Officer1.1yrsデータなし0.0030%
$ 328.4k
Scott Gunther
Senior Vice President of Quality & Regulatory Affairs7.3yrsデータなし0.022%
$ 2.4m

1.9yrs

平均在職期間

52yo

平均年齢

経験豊富な経営陣: CTLTの経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
John Greisch
Executive Chairman of the Board6.6yrsUS$400.86k0.028%
$ 3.0m
Alessandro Maselli
President2.2yrsUS$6.58m0.025%
$ 2.7m
Donald Morel
Independent Director8.8yrsUS$384.95k0.026%
$ 2.8m
Rolf Classon
Independent Director10.1yrsUS$384.95k0.0061%
$ 667.8k
Daniel R. Marshak
Member of Advisory Board9.1yrsデータなしデータなし
Jack Stahl
Independent Lead Director10.1yrsUS$395.11k0.015%
$ 1.7m
Gregory Lucier
Independent Director9.4yrsUS$387.61k0.00077%
$ 84.3k
J. Carroll
Independent Director9.2yrsUS$426.36k0.018%
$ 1.9m
Edward Robinson
Member of Advisory Board9.4yrsデータなしデータなし
Michael Buckley
Member of Advisory Board9.1yrsデータなしデータなし
Carolyn Bertozzi
Member of Scientfic & Advisory Board9.1yrsデータなしデータなし
Barry Buckland
Member of Advisory Board9.1yrsデータなしデータなし

9.1yrs

平均在職期間

67yo

平均年齢

経験豊富なボード: CTLTの 取締役会経験豊富 であると考えられます ( 9年の平均在任期間)。